These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Parallel evolution and differences in seroprevalence of SARS-CoV-2 antibody between patients with cancer and health care workers in a tertiary cancer centre during the first and second wave of COVID-19 pandemic: canSEROcov-II cross-sectional study. Ladoire S, Rederstorff E, Goussot V, Parnalland S, Briot N, Ballot E, Truntzer C, Ayati S, Bengrine-Lefevre L, Bremaud N, Coudert B, Desmoulins I, Favier L, Fraisse C, Fumet JD, Hennequin A, Hervieu A, Ilie S, Kaderbhai C, Lagrange A, Martin N, Mazilu I, Mayeur D, Palmier R, Simonet-Lamm AL, Vincent J, Zanetta S, Arnould L, Coutant C, Bertaut A, Ghiringhelli F. Eur J Cancer; 2022 Apr; 165():13-24. PubMed ID: 35189537 [Abstract] [Full Text] [Related]
29. Occupational characteristics associated with SARS-CoV-2 infection in the UK Biobank during August-November 2020: a cohort study. Yanik EL, Evanoff BA, Dale AM, Ma Y, Walker-Bone KE. BMC Public Health; 2022 Oct 10; 22(1):1884. PubMed ID: 36217157 [Abstract] [Full Text] [Related]
30. High prevalence of SARS-CoV-2 infection among symptomatic healthcare workers in a large university tertiary hospital in São Paulo, Brazil. Buonafine CP, Paiatto BNM, Leal FB, de Matos SF, de Morais CO, Guerra GG, Martuchelli MVV, Oliveira DBL, Durigon EL, Soares CP, Candido ED, Telezynski BL, Sáfadi MAP, Almeida FJ. BMC Infect Dis; 2020 Dec 02; 20(1):917. PubMed ID: 33267836 [Abstract] [Full Text] [Related]
31. Risk of Vaccine Breakthrough SARS-CoV-2 Infection and Associated Factors in Healthcare Workers of Trieste Teaching Hospitals (North-Eastern Italy). Basso P, Negro C, Cegolon L, Larese Filon F. Viruses; 2022 Feb 07; 14(2):. PubMed ID: 35215930 [Abstract] [Full Text] [Related]
32. A prospective study of risk factors associated with seroprevalence of SARS-CoV-2 antibodies in healthcare workers at a large UK teaching hospital. Cooper DJ, Lear S, Watson L, Shaw A, Ferris M, Doffinger R, Bousfield R, Sharrocks K, Weekes MP, Warne B, Sparkes D, Jones NK, Rivett L, Routledge M, Chaudhry A, Dempsey K, Matson M, Lakha A, Gathercole G, O'Connor O, Wilson E, Shahzad O, Toms K, Thompson R, Halsall I, Halsall D, Houghton S, Papadia S, Kingston N, Stirrups KE, Graves B, Townsend P, Walker N, Stark H, CITIID-NIHR BioResource COVID-19 Collaboration, De Angelis D, Seaman S, Dougan G, Bradley JR, Török ME, Goodfellow I, Baker S. J Infect; 2022 Nov 07; 85(5):557-564. PubMed ID: 36058413 [Abstract] [Full Text] [Related]
33. Non-occupational and occupational factors associated with specific SARS-CoV-2 antibodies among hospital workers - A multicentre cross-sectional study. Kahlert CR, Persi R, Güsewell S, Egger T, Leal-Neto OB, Sumer J, Flury D, Brucher A, Lemmenmeier E, Möller JC, Rieder P, Stocker R, Vuichard-Gysin D, Wiggli B, Albrich WC, Babouee Flury B, Besold U, Fehr J, Kuster SP, McGeer A, Risch L, Schlegel M, Friedl A, Vernazza P, Kohler P. Clin Microbiol Infect; 2021 Sep 07; 27(9):1336-1344. PubMed ID: 34020033 [Abstract] [Full Text] [Related]
34. Ethnic differences in SARS-CoV-2 infection and COVID-19-related hospitalisation, intensive care unit admission, and death in 17 million adults in England: an observational cohort study using the OpenSAFELY platform. Mathur R, Rentsch CT, Morton CE, Hulme WJ, Schultze A, MacKenna B, Eggo RM, Bhaskaran K, Wong AYS, Williamson EJ, Forbes H, Wing K, McDonald HI, Bates C, Bacon S, Walker AJ, Evans D, Inglesby P, Mehrkar A, Curtis HJ, DeVito NJ, Croker R, Drysdale H, Cockburn J, Parry J, Hester F, Harper S, Douglas IJ, Tomlinson L, Evans SJW, Grieve R, Harrison D, Rowan K, Khunti K, Chaturvedi N, Smeeth L, Goldacre B, OpenSAFELY Collaborative. Lancet; 2021 May 08; 397(10286):1711-1724. PubMed ID: 33939953 [Abstract] [Full Text] [Related]
37. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial. Cuadrado-Lavín A, Olmos JM, Cifrian JM, Gimenez T, Gandarillas MA, García-Saiz M, Rebollo MH, Martínez-Taboada V, López-Hoyos M, Fariñas MC, Crespo J. Trials; 2020 Jun 03; 21(1):472. PubMed ID: 32493494 [Abstract] [Full Text] [Related]
38. The prevalence and determinants of SARS-CoV-2 infections among healthcare workers, results of a cross-sectional study in the Silesian Voivodeship. Wojczyk M, Kowalska M. Int J Occup Med Environ Health; 2023 May 23; 36(2):201-213. PubMed ID: 37184147 [Abstract] [Full Text] [Related]
39. Prevalence and impact of persistent symptoms following SARS-CoV-2 infection among healthcare workers: A cross-sectional survey in the SIREN cohort. Foulkes S, Evans J, Neill C, Bishop J, Khawam J, Islam J, Atti A, Brown CS, Hopkins S, Price L, Hall V, SIREN study group. J Infect; 2024 Oct 23; 89(4):106259. PubMed ID: 39214242 [Abstract] [Full Text] [Related]
40. Risk assessment and antibody responses to SARS-CoV-2 in healthcare workers. Bansal A, Trieu MC, Mohn KGI, Madsen A, Olofsson JS, Sandnes HH, Sævik M, Søyland H, Hansen L, Onyango TB, Tøndel C, Brokstad KA, Bergen COVID-19 research group, Syre H, Riis ÅG, Langeland N, Cox RJ. Front Public Health; 2023 Oct 23; 11():1164326. PubMed ID: 37546332 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]